These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1978891)

  • 21. Prevalence and significance of anti-HCV antibodies.
    De Groote J
    Acta Gastroenterol Belg; 1991; 54(3-4):248-56. PubMed ID: 1665270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Will the real hepatitis C stand up?
    Lancet; 1989 Aug; 2(8658):307-8. PubMed ID: 2569106
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevalence of antibodies against hepatitis C virus in rheumatoid arthritis. Study using second-generation tests].
    Marson P; Vicarioto M; Cavasin F; Volante D; De Silvestro G
    Recenti Prog Med; 1991 Dec; 82(12):679-81. PubMed ID: 1667711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody to hepatitis C virus in German blood donors.
    Kühnl P; Seidl S; Stangel W; Beyer J; Sibrowski W; Flik J
    Lancet; 1989 Aug; 2(8658):324. PubMed ID: 2569115
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis C virus antibodies in patients with liver disease. The western Cape experience.
    Robson SC; du Toit JM; Brice EA; Bird AR; Brink NS
    S Afr Med J; 1991 Sep; 80(6):282-4. PubMed ID: 1656534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-hepatitis C viral antibodies in different pathological entities in Chile].
    Velasco M; Hurtado C; Brahm J
    Rev Med Chil; 1990 Aug; 118(8):895-6. PubMed ID: 1967082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of anti-HCV among spouses and offspring of anti-HCV positive subjects: an Italian multicentre study.
    Caporaso N; Ascione A; D'Antonio M; Di Costanzo GG; Galeota Lanza A; Tremolada F; Diodati G; Rumi MG; Parravicini ML; Pastore G
    Ital J Gastroenterol; 1995; 27(1):5-7. PubMed ID: 7540896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False-negative malaria rapid diagnostic tests in Rwanda: impact of Plasmodium falciparum isolates lacking hrp2 and declining malaria transmission.
    Kozycki CT; Umulisa N; Rulisa S; Mwikarago EI; Musabyimana JP; Habimana JP; Karema C; Krogstad DJ
    Malar J; 2017 Mar; 16(1):123. PubMed ID: 28320390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethics of screening for hepatitis C virus.
    Flegg PJ
    Lancet; 1989 Nov; 2(8673):1221. PubMed ID: 2572933
    [No Abstract]   [Full Text] [Related]  

  • 30. Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users.
    Filice G; Patruno S; Campisi D; Chiesa A; Orsolini P; Debiaggi M; Bruno R; Tinelli M
    New Microbiol; 1993 Jan; 16(1):35-42. PubMed ID: 7682283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 32. Seroprevalence of HBV and HCV markers among intravenous drug abusers and subjects affected by chronic active hepatitis.
    De Mercato R; Ciampi R; Romano A; Guarnaccia D; Siciliano V; Cantiello JP; Rippa O; Celentano U; Selva V; Romano C
    Boll Soc Ital Biol Sper; 1990 Sep; 66(9):841-7. PubMed ID: 2127365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low prevalence of anti-HCV antibodies among Italian Air Force recruits.
    D'Amelio R; Stroffolini T; Matricardi PM; Nisini R; Tosti ME; Trematerra M; Villano U; Rapicetta M; Mele A
    Scand J Infect Dis; 1995; 27(1):12-4. PubMed ID: 7784805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of hepatitis C antibody ELISA in patients with haemophilia.
    Colombo M; Rumi MG; Mannucci PM
    Lancet; 1990 Jun; 335(8701):1345. PubMed ID: 1971404
    [No Abstract]   [Full Text] [Related]  

  • 35. [The frequency of antibodies against delta virus in patients with HBs positive hepatitis].
    Ivaniushina VA; Ryzhova EV; Grudinin MP; Katorgina LG; Nikonova AN; Vinogradova EN; Iakovlev AA
    Vopr Virusol; 1996; 41(4):166-9. PubMed ID: 8999671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody to superoxide dismutase, autoimmune hepatitis, and antibody tests for hepatitis C virus.
    Ikeda Y; Toda G; Hashimoto N; Kurokawa K
    Lancet; 1990 Jun; 335(8701):1345-6. PubMed ID: 1971405
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatitis-C virus and hepatoma].
    Zala G; Havelka J; Altorfer J; Joller-Jemelka HJ; Risti B; Meier B; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1992 Feb; 122(6):194-7. PubMed ID: 1311125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation between specific and non-specific hepatitis C antibodies in chronic liver disease.
    Gray JJ; Wreghitt TG; Friend PJ; Wight DG; Sundaresan V; Calne RY
    Lancet; 1990 Mar; 335(8689):609-10. PubMed ID: 1968606
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhancement of ELISA cut-off reduces HCV-Ab false-positivity in patients with HBV, HDV and alcoholic liver disease.
    Andreone P; Cursaro C; Miniero R; Stefanini GF; Sprovieri G; Gasbarrini G
    Ital J Gastroenterol; 1991 Dec; 23(9):567-8. PubMed ID: 1662091
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevalence and significance of ant-HCV-antibodies in ambulatory patients with raised transaminases].
    Meier B; Joller H; Grob P; Ammann R; Altorfer J
    Schweiz Med Wochenschr; 1991 May; 121(21):804-6. PubMed ID: 1647550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.